Folks,
We are exploring next steps since the Keytruda alone has not prevented a second mets from occurring on my husband's leg.
Is there anyone out there who is involved in this clinical trial:
the ongoing phase III KEYNOTE-252/ECHO-301 study is exploring the efficacy, safety, and tolerability of the PD-1 inhibitor pembrolizumab (Keytruda) with the IDO1 inhibitor epacadostat.
If so, I would appreciate feedback on side effects and experience.
With thanks,
Missy